Rutgers Cancer Institute of NJ /ID# 161080 — New Brunswick, New Jersey

Rutgers Cancer Institute of NJ /ID# 161080 is a clinical research site located in New Brunswick, New Jersey, United States 08903.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Rutgers Cancer Institute of NJ /ID# 161080 has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors Cancer.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Brunswick

Browse all research sites in New Jersey · View every site in New Brunswick

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rutgers Cancer Institute of NJ /ID# 161080?

Rutgers Cancer Institute of NJ /ID# 161080 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rutgers Cancer Institute of NJ /ID# 161080 conducted?

Rutgers Cancer Institute of NJ /ID# 161080 has 1 clinical trials on record. Their work covers Advanced Solid Tumors Cancer.

Is Rutgers Cancer Institute of NJ /ID# 161080 accredited by Crixeo Clinical Trials?

Rutgers Cancer Institute of NJ /ID# 161080 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rutgers Cancer Institute of NJ /ID# 161080?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.